Skip to main content
. 2014 Apr 11;289(21):14968–14980. doi: 10.1074/jbc.M114.563684

TABLE 1.

Primer pairs used for cloning and mutagenesis

The underlined sequence indicates the restriction sites used for cloning. Boldface sequences indicate site-directed mutations. A conservative mutation was made within GLP-1 to remove an internal EcoRI restriction site. Boldface and underlined text indicates a stop codon.

Fusion construct Oligonucleotide sequence pair (5′ → 3′)
Fc (for construction of Fc alone and Fc-glucagon) Forward, 5′-AAGCTTGGCATGGATCAATTC
Reverse, 5′-GGATCCAGGCCTACCCGCAGA
Fc stop mutation Forward, 5′-GACCATCTCCCGGTCTCCGGGTTAGCCTGGATCC
Reverse, 5′-GGACTAGTGGATCCAGGCTAACCCGGAGACCGGGAG
Fc-glucagon frame shift Forward, 5′-CCTGGATCCACTCAGTCCAGTGTGGTGG
Reverse, 5′-CCACCACACTGGACTGAGTGGATCCAGG
Glucagona Forward, 5′-GAATTCCATTCACAGGGAACA
Reverse, 5′-GCGGCCGCCTAGGTGTTCATCAG
L26P-glucagon amplification Forward, 5′-GAATTCCATTCACAGGGAACA
Reverse, 5′-GCGGCCGCCTAGGTGTTCATCGG
R18Q-glucagon mutagenesis Forward, 5′-AAATACCTGGACTCCCGCCAAGCCCAAGATTTTG
Reverse, 5′-CAAAATCTTGGGCTTGGCGGGAGTCCAGGTATTT
L14P-glucagon mutagenesis Forward, 5′-TACAGCAAATACCCGGGACTCCCGCCGAGCC
Reverse, 5′-GGCTCGGCGGGAGTCCGGGTATTTGCTGTA
Fc (for construction with GLP-1, GLP-2, glicentin, MPGF) Forward, 5′-GCTAGCATGGATCAATTCCGATGG
Reverse, 5′-AAGCTTACCCGGAGACCGGGAGATGG
GLP-1(1–37)b Forward, 5′-GGATCCCACGATGAGTTTGAGAGG
Reverse, 5′-GAATTCTCCTCTGCCTTTCACC
GLP-1(7–37)b Forward, 5′-GGATCCCACGCTGAAGGGACC
Reverse, 5′-GAATTCTCCTCTGCCTTTCACC
GLP1 Glu-27 mutagenesis Forward, 5′-GGCCAGGCTGCAAAGGAGTTCATTGCTTGG
Reverse, 5′-CCAAGCAATGAACTCCTTTGCAGCCTGGCC
GLP-1 stop codon mutagenesis Forward, 5′-GGTGAAAGGCAGAGGATGAGAATTCTGCA GATATCCTTAAG
Reverse, 5′-AAGGATATCTGCAGAATTCTCATCCTCTGCC TTTCACCAGC
GLP-2b Forward, 5′-GGATCCCATGCGGACGGCTCCTTC
Reverse, 5′-GAATTCGTCAGTGATTTTGGTTTG
GLP-2 stop codon mutagenesis Forward, 5′-CAAACCAAAATCACTGACTAGGAATTCTGCAGA TATCCTTAAGT
Reverse, 5′-AGGATATCTGCAGAATTCCTAGTCAGTGATTTT GGTTTGAATC
D3Q-GLP-2 mutagenesis Forward, 5′-GGATCCCATGCGCAGGGCTCCTTCTCC
Reverse, 5′-GGAGAAGGAGCCCTGCGCATGGGATCC
D8K,E9K,N11K,D15K GLP-2 mutagenesis Forward, 5′-GCTCCTTCTCCAAGAAGATGAAGACGATTCTCAAGAGTCTTGCC
Reverse, 5′-GGCAAGACTCTTGAGAATCGTCTTCATCTTCTTGGA GAAGGAGC
Glicentinb Forward, 5′-GGATCCCATTCCCTTCAGGACACGGAGG
Reverse, 5′-GAATTCCTAGCGTTTGGCAATGTTGTTCCTGTTC
MPGFb Forward, 5′-GGATCCCACGATGAGTTTGAGAGGCACGC
Reverse, 5′-GAATTCCTATTTCTTGTCAGTGATTTTGGTTTGAATCA
Oxyntomodulinb Forward, 5′-CTCGGATCCCATTCACAGGGAACATTCACCAGTGACTACAG
Reverse, 5′-GTGAATGGGATCCGAGCTCGGTACCAAGCTTACCCG

a Constructs used a flexible 10-amino acid linker (sequence GSTQSSVVEF).

b Constructs used a flexible 8-amino acid linker (sequence KLGTELGS).